With the aim of clarifying the survival benefit in the subgroup of patients with ESCC with low PD-L1 expression, after deriving individual patient data (IPD) from the reported KM curves, we investigated unreported PD-L1 subgroups in pivotal trials and conducted a series of IPD pooled analyses. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.